Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biomarker Test Diagnoses Placental Function

By LabMedica International staff writers
Posted on 17 Jan 2011
A blood test can identify a biomarker that can aid in the diagnosis of early onset preeclampsia, a leading cause of maternal and perinatal mortality and morbidity.

The measurement of the biomarker, Placental Growth Factor (PlGF), which is involved in placental development, provides a highly sensitive and specific indication of the placental dysfunction, which leads to early onset preeclampsia.

The new test, can aid clinicians in the diagnosis of early onset preeclampsia by measuring the level of PlGF in a plasma sample. More...
After separating plasma from a whole blood sample, the system provides rapid and accurate quantification of PlGF. The test can be performed in a laboratory or clinical setting and it provides results within 15 minutes.

A low PlGF measurement alerts the clinician to the high probability of preeclampsia. PlGF is made by the placenta and it encourages blood vessel growth. PlGF circulates at high concentrations in normal pregnancy, with levels peaking at 32 weeks and decreasing towards full term. However, the concentration of PlGF is significantly decreased in women with early onset preeclampsia. The Alere Triage PLGF test, (Morges, Switzerland), is a reliable diagnostic blood test which potentially can be used close to the mother without the need for elaborate equipment or trained laboratory staff.

Identifying early onset preeclampsia is important because the condition can escalate into dangerous crises. Women with early onset preeclampsia must be closely monitored to ensure the pregnancy is ended by delivery before the onset of serious complications. By accurately identifying which women have placental dysfunction, healthcare resources can be applied to the women at greatest risk of complications.

Christopher Redman, FCRP, FRCOG, an emeritus professor at Oxford University, (Oxford, UK), said, "No complication of human pregnancy is both so common and so dangerous for both mother and baby as preeclampsia. Yet its detection is fraught with uncertainties leading to over management for many expectant mothers while others have serious problems that go undetected.”

Related Links:

Alere
Oxford University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
POC Immunoassay Analyzer
Procise DX
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.